Hanjoong Jo, PhD
Georgia Institute of Technology
H-index: 79
North America-United States
Top articles of Hanjoong Jo, PhD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Atherosclerotic three-layer nanomatrix vascular sheets for high-throughput therapeutic evaluation | Biomaterials | Jun Chen Xixi Zhang Robbie Cross Jr Yujin Ahn Gillian Huskin | 2024/3/1 |
Simulated microgravity improves maturation of cardiomyocytes derived from human induced pluripotent stem cells | Scientific Reports | Parvin Forghani Aysha Rashid Lawrence C Armand David Wolfson Rui Liu | 2024/1/26 |
HEG1 protects against atherosclerosis by regulating stable flow-induced KLF2/4 expression in endothelial cells | Circulation | Ian A Tamargo Kyung In Baek Chenbo Xu Dong Won Kang Yerin Kim | 2023 |
Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204 | Frontiers in Physiology | Leonardo Y Tanaka Sandeep Kumar Lucas F Gutierre Celso Magnun Daniela Kajihara | 2024/4/4 |
Hyperoxia impairs induced pluripotent stem cell-derived endothelial cells and drives an atherosclerosis-like transcriptional phenotype | JVS-Vascular Science | SM Carr Katherine Owsiany Ottis Scrivner Dylan McLaughlin Hanjoong Jo | 2024/3/7 |
The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells | Diseases | Kun Huang Mark Pitman Olanrewaju Oladosu Jing Echesabal-Chen Lucia Vojtech | 2023/6/24 |
Single-Cell RNA sequencing investigation of female-male differences under PAD conditions | Frontiers in Cardiovascular Medicine | Gloriani Sánchez Marrero Nicolas Villa-Roel Feifei Li Christian Park Dong-Won Kang | 2023 |
CTGF is a Modifiable Mediator of Flow-dependent Atherosclerosis under Peripheral Artery Disease Conditions | medRxiv | Feifei Li Sandeep Kumar Anastassia Pokutta-Paskaleva Victor O Omojola Dong-Won Kang | 2023 |
Nuclear FAK in endothelium: An intrinsic inhibitor of NF-κB activation in atherosclerosis | Atherosclerosis | James M Murphy Kyuho Jeong Duyen Thi Kieu Tran Donna L Cioffi Pamela Moore Campbell | 2023/8/1 |
Conserved miR-370-3p/BMP-7 axis regulates the phenotypic change of human vascular smooth muscle cells | Scientific Reports | Yerin Kim Namhee Yu Ye Eun Jang Eunkyung Lee Yeonjoo Jung | 2023/2/10 |
Constructing Lipoparticles Capable of Endothelial Cell-Derived Exosome-Mediated Delivery of Anti-miR-33a-5p to Cultured Macrophages | Current Issues in Molecular Biology | Jing Echesabal-Chen Kun Huang Lucia Vojtech Olanrewaju Oladosu Ikechukwu Esobi | 2023/7/4 |
Blood flow patterns switch VEGFR2 activity through differential S-nitrosylation and S-oxidation | Cell Reports | Dong Hoon Kang Yerin Kim Seongchun Min Su Youn Lee Ka Young Chung | 2023/11/28 |
Myeloid CCN3 protects against aortic valve calcification | Cell Communication and Signaling | Peinan Tu Qian Xu Xianming Zhou Nicolas Villa-Roel Sandeep Kumar | 2023/1/20 |
Endothelial CCRL2 induced by disturbed flow promotes atherosclerosis via chemerin-dependent β2 integrin activation in monocytes | Cardiovascular Research | Chaojun Tang Guona Chen Fan Wu Yiren Cao Fei Yang | 2023/7 |
Nanodiscoidal Nucleic Acids for Gene Regulation | ACS Chemical Biology | Radhika Sharma Steven Narum Shuhong Liu Yixiao Dong Kyung In Baek | 2023/11/1 |
Low oscillatory shear stress regulates Weibel-Palade body size and vWF release. | bioRxiv | Ashley Money Harriet J Todd Hanjoong Jo David J Beech Lynn McKeown | 2023 |
Label‐free atherosclerosis diagnosis through a blood drop of apolipoprotein E knockout mouse model using surface‐enhanced Raman spectroscopy validated by machine learning algorithm | Bioengineering & Translational Medicine | Sanghwa Lee Miyeon Jue Minju Cho Kwanhee Lee Bjorn Paulson | 2023/7 |
Flow-induced reprogramming of endothelial cells in atherosclerosis | Ian A Tamargo Kyung In Baek Yerin Kim Christian Park Hanjoong Jo | 2023/11 | |
Role of Cellular Communication Network Factor 2 and Male Sex on Flow-mediated Arterial Remodeling and Atherosclerotic Plaque Formation | JVS-Vascular Science | Luke P Brewster Feifei Li Victor Omojola Sandeep Kumar Rudolph L Gleason | 2022/1/1 |
Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors | 2022/1/18 |
Co-Authors
